DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GS-9256

Generic Name: GS-9256

Drug Type: Small Molecule

Chemical Formula: C_₄₆H_₅₆ClF_₂N_₆O_₈PS

CAS Number: 1001094-46-7

Unique Ingredient Identifier: 8V42Y78HRU

Overview

GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

Background

GS-9256 has been used in trials studying the treatment of HCV Infection and Chronic Hepatitis C Infection.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Response-Guided Duration of Combination Therapy With GS-9190, GS-9256, Pegasys® and Copegus® in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Phase 2

Completed

Posted: 2010/10/21

Sponsor:Gilead Sciences

Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection

Phase 2

Completed

Posted: 2010/02/22

Sponsor:Gilead Sciences

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy